Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
235 studies found for:    neurocutaneous
Show Display Options
Rank Status Study
1 Completed
Has Results
Repair of Soft Tissue Defect of the Finger Using the Heterodigital Neurocutaneous Island Flap
Conditions: Sensory Reconstruction of the Volar Aspect of the Finger;   The Heterodigital Neurocutaneous Island Flap
Intervention: Device: the neurocutaneous island flap
2 Completed Reconstruction of a Neurocutaneous Defect of the Proximal Phalanx With a Heterodigital Arterialized Nerve Pedicle Flap
Condition: Complex Digital Injuries
Intervention: Procedure: Composite Flap
3 Completed
Has Results
Repair of Infective Wound Associated With Nerve Defect in the Finger Using A Bipedicled Nerve Flap
Conditions: Infection Wound;   Disruption of Nerve Repair
Intervention: Device: Nerve flap
4 Recruiting Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers
Condition: Sjogren-Larsson Syndrome (SLS)
5 Completed Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome
Condition: Sturge- Weber Syndrome
Intervention: Drug: Drug: Topical Rapamycin
6 Completed Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I
Conditions: Neurofibromatosis Type 1;   Von Recklinghausen Disease;   NF1
7 Completed Sensory Reconstruction of the Digits
Condition: Soft Tissue Defect of Digit
Intervention: Procedure: innervated sensate flap
8 Completed Longitudinal Study of Neurologic, Cognitive, and Radiologic Outcomes of PHACE Syndrome
Condition: PHACE Syndrome
9 Recruiting Susceptibility Genes in Autism Spectrum Disorders
Condition: Autism Spectrum Disorders
10 Recruiting A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
Condition: Von Hippel-Lindau Syndrome
Interventions: Drug: Ranibizumab;   Drug: E10030
11 Recruiting Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients
Condition: Von Hippel-Lindau Disease
12 Enrolling by invitation Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?
Condition: Von Hippel-Lindaus Disease
13 Completed Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease
Condition: Von Hippel-Lindau Disease
Intervention: Drug: Sunitinib
14 Recruiting Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease
Condition: Von Hippel-Lindau Disease
15 Completed EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
Condition: Hippel-Lindau Disease
Intervention: Drug: EYE001
16 Active, not recruiting Von Hippel-Lindau Disease Genetic Epidemiology Study
Conditions: Von Hippel Lindau Disease;   Kidney Neoplasms
17 Completed Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
Conditions: Coats' Disease;   Idiopathic Retinal Telangiectasia;   Retinal Angiomatous Proliferation;   Polypoidal Choroidal Vasculopathy;   Pseudoxanthoma Elasticum;   Pathological Myopia;   Multi-focal Choroiditis;   Rubeosis Iridis;   Von Hippel Lindau Disease;   BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)
Intervention: Drug: ranibizumab injection (0.5 mg)
18 Active, not recruiting Pazopanib in Von Hippel-Lindau (VHL) Syndrome
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Pazopanib
19 Terminated
Has Results
TKI 258 in Von Hippel-Lindau Syndrome (VHL)
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Dovitinib
20 Terminated
Has Results
Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Sunitinib Malate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.